People · Operator
Named in public records as an officer, director or promoter · active 2008–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vaccinogen Inc | — | Biotechnology | Series A | $23.7M | $21.7M | 2008 |
David L. Hatt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David L. Hatt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gregory H. Barnhill | 1 | 3 |
| Michael L. Kranda | 1 | 2 |
| Michael G. Hanna, Jr. | 1 | 1 |
| John L. Nicolis | 1 | 1 |
| Andrew L. Tussing | 1 | 1 |
| Alan L. Cohen | 1 | 1 |
| Tony L. Caplin | 1 | 1 |
| Michael G. Hagerman | 1 | 1 |
| Hakan G. Edstrom | 1 | 1 |
| Daniel L. Fitzgerald | 1 | 1 |
| Anders G. Halldin | 1 | 1 |
| Daniel L. Kane | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.